Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113087714B discloses a novel Rh(II)-catalyzed N-H insertion method for axial chiral aryl indole carbazoles, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.
Novel binaphthyl phosphoric acid catalysis enables mild synthesis of antitumor intermediates with significant supply chain and cost advantages for global buyers.
Patent CN117088826B enables visible light synthesis of oxazoles. Offers green chemistry solutions for reliable pharmaceutical intermediates supplier partners seeking cost reduction.
Novel visible light photocatalysis method for C2-difluoroalkylbenzimidazole derivatives offers mild conditions and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN113307790B reveals a metal-free oxidative cyclization route for 1,2,4-triazoles. Discover cost-effective manufacturing and scalable supply chain solutions for high-purity intermediates.
Novel patent CN115286628B details efficient carbonylation for high-purity intermediates, offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN116199614B reveals high ee synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN107936025B enables mild synthesis of chiral pyrazolidones. Eliminates heavy metals for cost reduction and supply chain reliability in pharmaceutical manufacturing.
Patent CN112812084B reveals a cost-effective iron phthalocyanine catalyzed route for benzofuran intermediates, offering significant supply chain and purity advantages.
Patent CN112209947A reveals a mild organocatalytic route for chiral indoxazinones, offering high enantioselectivity and cost reduction in API manufacturing.
Novel chiral synthesis method offers high yield and enantioselectivity for antitumor drug intermediates, ensuring supply chain stability.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.
Patent CN115850178B reveals high-purity synthesis for agrochemical intermediates. Enhanced selectivity reduces costs and ensures supply chain reliability for global buyers.
Novel 5 5 tetralone skeleton chiral phosphoric acid patent CN105111228A offers enhanced acidity and enantioselectivity for pharmaceutical intermediates with cost effective synthesis
Novel chiral phosphoric acid catalyzed method for high-purity tetrahydroacridines. Reduces steps and improves enantioselectivity for pharma intermediates.
Novel axial chiral indole-furan catalyst patent CN117720537B enables mild asymmetric synthesis. Offers high enantioselectivity and cost-effective manufacturing for reliable pharma intermediate supply chains.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles. High yield, mild conditions, suitable for pharmaceutical intermediate manufacturing.
Patent CN111039767B reveals a metal-free route for deuterated aldehydes using triazole carbene, offering high deuteration rates and cost efficiency for pharmaceutical supply chains.
Patent CN113429349A reveals a recyclable Cu/g-C3N4 method for high-yield benzimidazole synthesis, offering cost-effective pharma intermediate solutions.